Viamet Pharmaceuticals, Inc. Reorganization and Spin-off
In December 2011, our lawyers represented Viamet Pharmaceuticals, Inc. in a reorganization under which Viamet Pharmaceuticals, Inc. became a wholly-owned subsidiary of a new parent LLC entity, Viamet Pharmaceuticals Holdings, LLC. and VPS-1, Inc., a spin-off. North Carolina-based Viamet Pharmaceuticals Holdings, LLC, through its subsidiaries, discovers and develops inhibitors of validated metalloenzymes.
Posted on December 30, 2011
RELATED PROFESSIONALS
RELATED SERVICES
INDUSTRIES
Disclaimer
Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.